-
While the oral contraceptive (OC) Yasmin has been the focus of interest in the United States for its potential in treating premenstrual syndrome, its safety has been questioned by Dutch medical officials, who are calling for more epidemiological data on the potential risk for venous thrombosis.
-
What is your approach when it comes to oral contraceptives and women who smoke? What is your facilitys standard practice for informing patients on Pap test results?
-
Without fanfare, the Bush administration has issued an important report to Congress on nondirective pregnancy options counseling in family planning clinics. Specifically, the report sought to assess the extent to which adoption information and referral is provided as part of nondirective counseling in publicly funded clinics.
-
Four years after its initial announcement to revive the Today contraceptive sponge, the company responsible for its rebirth finally has released the product in Canada and says it is pressing for Food and Drug (FDA) approval to market the device over the counter in the United States.
-
Scientists recently conducted an international survey to explore womens willingness to use a contraceptive that induces amenorrhea.
-
Epidemiological evidence presented at a recent Bethesda, MD-based National Cancer Institute (NCI) workshop could help end a longstanding debate on the question of induced abortion and risk of breast cancer.
-
The news is in from the worlds first large-scale trial of a HIV vaccine, and it isnt good: The vaccine failed to achieve a statistically significant reduction of HIV infection within its study population as a whole.
-
Its back to the research drawing board in the search for more treatment options for genital herpes. A clinical trial of an experimental drug, resiquimod, has been suspended since preliminary data showed it was not as effective as expected.
-
-
As HIV continues to spread faster in the South than in any other region, health officials from 13 states are sending out a strong message: The South needs help fighting an epidemic that is becoming increasingly rural, female, African-American, and poor.
